Poland· PL-100527764
Pancuronium Inresa
A pancuronium product containing pancuronii bromidum, registered in Poland by Delfarma Sp. z o.o.. The same ATC class is registered in 5 of our 19 countries.
Checked against URPL (Poland) on
Informational only — not a medical device.
Where it is registered
Pancuronium is registered in 5 of 19 countries.
Countries holding a registration under ATC M03AC01 (pancuronium), each read from that country’s own register.
- This record: Poland, from URPL (Poland)
- 3 of them publish a price we can compare per daily dose
Pancuronium · ATC M03AC01
5 / 19 countries
- Finlandprice
- Germany
- Norwayprice
- Polandprice
- United Kingdom
The record
At a glance
URPL (Poland)- Active substance
- Pancuronii bromidum
- Manufacturer
- Delfarma Sp. z o.o.
- Country
- Poland (PL)
- ATC code
- M03AC01
- ATC class
- Pancuronium
- Defined daily dose
- 6.3 mg, P
- Reimbursed
- Not published by this register
- Source register
- URPL (Poland)
- Last checked
- September 27, 2026
Packs & prices · 1
- gtin05909991587826
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Interactions
108 interactions on record for pancuronium.
Graded by severity as the source publishes them — 12 severe. Severity grades are free for everyone; mechanism and management come with Growth.
- Severity for every pair — free, no plan needed
- The source, licence and sync date on every record
- Mechanism and what to do for each pair — Growth plan
Pancuronium · interactions on record
108 records
- 12 severe
- 62 moderate
- 4 minor
- 30 info
Most severe, free to view
- NeomycinA07AA01severe
- StreptomycinA07AA04severe
- Polymyxin BA07AA05severe
- ParomomycinA07AA06severe
- Interaction severity from DDInter 2.0 (Xiong G. et al., Nucleic Acids Res.), licensed CC BY-NC 4.0 — free for non-commercial use only; not covered by the Drug Database commercial licence.
Same medicine, other countries
Pancuronium in 4 other countries
What each register calls a product with the same active substance — salts and hydrates count as the same.
- NorwayPancuronium
- FinlandPavulonN.V. Organon
- United KingdomPancuronium bromide 4mg/2ml solution for injection ampoulesMercury Pharma Group Ltd
- GermanyPancuroniumbromid InresaInresa Arzneimittel Gmbh
Authorised across Europe · EMA
The same active substance is authorised in 2 EEA countries. Names it is sold under:
- Germany · Pancuroniumbromid Inresa, Pancuroniumbromid Panpharma
- Portugal · Brometo De Pancurónio Hikma
Source: European Medicines Agency, Article 57 product data.
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of URPL (Poland). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/219f68fb-2a52-4005-9420-6bfb4d7cd4ef GET /v1/drugs/219f68fb-2a52-4005-9420-6bfb4d7cd4ef?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"form": "Roztwór do wstrzykiwań",
"source": "urpl",
"strength": "2 mg/ml",
"packaging": "05909991587826 ¦ Lz ¦ 164515\n10 amp. 2 ml",
"substance": "Pancuronii bromidum 2 mg/ml",
"common_name": "Pancuronii bromidum",
"pl_product_id": "100527764",
"pozwolenie_nr": "352/25",
"auth_procedure": "IR",
"authorisation_validity": "2030-11-06"
}See everything about pancuronium.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.